Patients with hyperlipidemia had worse TPO agent reactivity than those with normal lipid levels (58.9% vs. 75.4%, P = 0.04, Table 2, and 39.5% vs. 69.5%, P = 0.04 after PSM, Supplemental Table 2). The gene discussed is TPO; the disease is hyperlipidemia.